Patent details

Basic Information

Publication number:

EP1335725

PCT Application Number:

PCT/US/2001/047324

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019961754

PCT Publication Number:

WO/2002/040000

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF CCI-779 AS AN ANTINEOPLASTIC AGENT

French Title of Invention:

UTILISATION DU CCI-779 EN TANT QU'AGENT ANTINEOPLASIQUE

German Title of Invention:

VERWENDUNG VON CCI-779 ALS ANTINEOPLASTISCHES MITTEL

SPC Number:

Dates

Filing date:

13/11/2001

Grant date:

30/04/2008

EP Publication Date:

30/04/2008

PCT Publication Date:

23/05/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/08/2003

EP B1 Publication Date:

30/04/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/11/2010

Expiration date:

13/11/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/11/2001

 

 

Name:

Wyeth

Address:

Five Giralda Farms, Madison, NJ 07940-0874, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

30/04/2008

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

GIBBONS James, Joseph, Jr.

Address:

United States (US)

2

Name:

FROST Philip

Address:

United States (US)

3

Name:

DISCAFANI-MARRO Carolyn, Mary

Address:

United States (US)

4

Name:

DUKART Gary

Address:

United States (US)

5

Name:

SPEICHER Lisa, Anne

Address:

United States (US)

Priority

Priority Number:

249077 P

Priority Date:

15/11/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/436;

Filing date	Document type	Number of pages